Immunological barriers and engineering strategies for CAR-T cell therapy in acute myeloid leukemia - Top-Institutions - MDSpire

Immunological barriers and engineering strategies for CAR-T cell therapy in acute myeloid leukemia

  • By

  • Ya Wang

  • Tiantian Yu

  • Ming Wang

  • Li Yu

  • July 15, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of Pennsylvania
    University of Pennsylvania

    Philadelphia, PA

    Key Differentiators

    • Hematology
    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Oncology

  • #3

    National Cancer Institute
    National Cancer Institute

    Bethesda, MD

    Key Differentiators

    • Hematology
    • Oncology

  • #4

    Fred Hutchinson Cancer Research Center
    Fred Hutchinson Cancer Research Center

    Seattle, WA

    Key Differentiators

    • Hematology
    • Oncology

Original Source(s)

Immunological barriers and engineering strategies for CAR-T cell therapy in acute myeloid leukemia

  • by Ya Wang, Tiantian Yu, Ming Wang, Li Yu

  • July 15, 2026

Related Content

Helicobacter pylori infection in gastric cancer patients in French Guiana: a hospital-based study (2018–2023)

Prognostic significance of extracapsular extension in patients with non-small cell lung cancer following neoadjuvant chemoimmunotherapy: a retrospective cohort study

Predictive modeling for survival-related outcomes in lung cancer patients with brain metastases: a mini-review